BEAM
Price
$22.03
Change
+$0.57 (+2.66%)
Updated
Jul 10 closing price
Capitalization
2.16B
32 days until earnings call
LCTX
Price
$1.02
Change
-$0.04 (-3.77%)
Updated
Jul 10 closing price
Capitalization
242.06M
27 days until earnings call
Interact to see
Advertisement

BEAM vs LCTX

Header iconBEAM vs LCTX Comparison
Open Charts BEAM vs LCTXBanner chart's image
Beam Therapeutics
Price$22.03
Change+$0.57 (+2.66%)
Volume$3.31M
Capitalization2.16B
Lineage Cell Therapeutics
Price$1.02
Change-$0.04 (-3.77%)
Volume$1.88M
Capitalization242.06M
BEAM vs LCTX Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. LCTX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and LCTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (BEAM: $22.03 vs. LCTX: $1.02)
Brand notoriety: BEAM and LCTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 162% vs. LCTX: 71%
Market capitalization -- BEAM: $2.16B vs. LCTX: $242.06M
BEAM [@Biotechnology] is valued at $2.16B. LCTX’s [@Biotechnology] market capitalization is $242.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileLCTX’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • LCTX’s FA Score: 0 green, 5 red.
According to our system of comparison, LCTX is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while LCTX’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • LCTX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than LCTX.

Price Growth

BEAM (@Biotechnology) experienced а +10.09% price change this week, while LCTX (@Biotechnology) price change was +0.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

LCTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.16B) has a higher market cap than LCTX($242M). LCTX YTD gains are higher at: 102.985 vs. BEAM (-11.169). LCTX has higher annual earnings (EBITDA): -20.72M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. LCTX (47.9M). LCTX has less debt than BEAM: LCTX (2.24M) vs BEAM (158M). BEAM has higher revenues than LCTX: BEAM (63.6M) vs LCTX (9.56M).
BEAMLCTXBEAM / LCTX
Capitalization2.16B242M892%
EBITDA-399.03M-20.72M1,925%
Gain YTD-11.169102.985-11%
P/E RatioN/AN/A-
Revenue63.6M9.56M665%
Total Cash1.22B47.9M2,547%
Total Debt158M2.24M7,041%
FUNDAMENTALS RATINGS
LCTX: Fundamental Ratings
LCTX
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
65
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMLCTX
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 19 days ago
85%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XVIPF30.950.45
+1.48%
Xvivo Perfusion AB
BDRFY25.840.26
+1.02%
Beiersdorf AG
GGAZF0.790.01
+0.69%
Goldgroup Mining Inc.
VACBF0.19N/A
N/A
NYKODE THERAPEUTICS AS
CBUMY30.62-18.88
-38.14%
China National Buildings Material

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
-3.77%
MDGL - LCTX
43%
Loosely correlated
+1.96%
ARCT - LCTX
37%
Loosely correlated
-2.10%
BEAM - LCTX
36%
Loosely correlated
+2.66%
ABCL - LCTX
36%
Loosely correlated
+9.25%
PYXS - LCTX
35%
Loosely correlated
+1.71%
More